Literature DB >> 15378696

Diverse proteomic alterations in gastric adenocarcinoma.

Qing-Ye He1, Yim Hing Cheung, Suet Yi Leung, Siu Tsan Yuen, Kent-Man Chu, Jen-Fu Chiu.   

Abstract

Gastric adenocarcinoma is one of the most common cancers in Asian countries including China. Although its incidence rates in the West are lower than that in Asia, gastric cancer is still a major health problem worldwide, being second only to lung cancers in the number of deaths it causes. Helicobacter pylori infection has been identified as the major pathogen, but the detailed pathogenesis of gastric carcinoma remains elusive. Due to the lack of suitable and specific biomarkers for early detection, most cases of the disease are diagnosed at late stages and the survival rate is low. In this study, we used a proteomic approach to globally analyze the protein profiles of paired surgical specimens of primary gastric adenocarcinoma and nontumor mucosa aiming at identifying specific disease-associated proteins as potential clinical biomarkers and for carcinogenetic study. Compared to nontumor tissues, multiple protein alterations were found in tumor tissues. Some of these alterations involve variations in the expression of cytoskeleton proteins, including an increase in cytokeratin 8 and tropomyosin isoform and a decrease in cytokeratin 20. Co-up-regulations of heat-shock proteins and glycolytic enzymes were observed in tumor tissues, indicating self-protective efforts of cells and the growing energy requirement during malignant transformation. Diverse regulations also occurred with proteins involved in cell proliferation and differentiation, such as GMP reductase 2 and creatine kinase B, and proteins bearing potential tumor suppressor activities, including prohibitin and selenium binding protein 1. More interestingly, a human stomach-specific protein, 18 kDa antrum mucosa protein, was found to be dramatically under-expressed in cancer tissues, implicating a possible special pathological role for this protein in gastric carcinogenesis. Further comprehensive evaluation by globally considering the altered factors may result in the discovery of a biomarker index for effective assessment of the disease and may provide in-depth information for better understanding the pathogenesis of gastric cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15378696     DOI: 10.1002/pmic.200300916

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  42 in total

1.  Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein.

Authors:  Wenfeng Fang; Marci L Goldberg; Nicole M Pohl; Xiuli Bi; Chang Tong; Bin Xiong; Timothy J Koh; Alan M Diamond; Wancai Yang
Journal:  Carcinogenesis       Date:  2010-06-07       Impact factor: 4.944

Review 2.  Molecular cross-talk between members of distinct families of selenium containing proteins.

Authors:  Emmanuel Ansong; Wancai Yang; Alan M Diamond
Journal:  Mol Nutr Food Res       Date:  2013-11-13       Impact factor: 5.914

3.  Different expression of S100A8 in malignant and benign gallbladder diseases.

Authors:  Wei Wang; Kai-Xing Ai; Zhou Yuan; Xin-Yu Huang; Hui-Zhen Zhang
Journal:  Dig Dis Sci       Date:  2012-07-18       Impact factor: 3.199

4.  Altered expression of selenium-binding protein 1 in gastric carcinoma and precursor lesions.

Authors:  Jin Zhang; Na Zhan; Wei-guo Dong
Journal:  Med Oncol       Date:  2010-05-18       Impact factor: 3.064

5.  Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma.

Authors:  Jin Zhang; Wei-Guo Dong; Jun Lin
Journal:  Med Oncol       Date:  2010-03-31       Impact factor: 3.064

6.  Inhibition of focal adhesion kinase induces apoptosis in human gastric carcinoma cells (SGC-7901).

Authors:  Jiyou Li; Qingfeng Meng; Yu Sun; Huadong Qing
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

7.  Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma.

Authors:  Constantinos T Giaginis; Stephanie Vgenopoulou; Gerasimos S Tsourouflis; Ekaterini N Politi; Gregorios P Kouraklis; Stamatios E Theocharis
Journal:  Pathol Oncol Res       Date:  2008-11-06       Impact factor: 3.201

8.  Immunohistochemical expression and mutation study of Prohibitin gene in Indian female breast cancer cases.

Authors:  Mohammad Zeeshan Najm; Shuaib Zaidi; Waseem Ahmad Siddiqui; Syed Akhtar Husain
Journal:  Med Oncol       Date:  2013-05-29       Impact factor: 3.064

9.  Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer.

Authors:  Karen Stammer; Seby L Edassery; Animesh Barua; Pincas Bitterman; Janice M Bahr; Dale Buchanan Hales; Judith L Luborsky
Journal:  Gynecol Oncol       Date:  2008-02-13       Impact factor: 5.482

10.  Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts.

Authors:  Nicole M Pohl; Chang Tong; Wenfeng Fang; Xiuli Bi; Tianhong Li; Wancai Yang
Journal:  PLoS One       Date:  2009-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.